Inventor

Toni Kline

Inventor
Seattle, WA, US

Overview

22→
Patents
1993–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides18%
Y02ATechnologies for adaptation to climate change12%
C07DHeterocyclic compounds8%
Y10TTechnical subjects covered by former us classification8%
C07CAcyclic or carbocyclic compounds4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,844,090Hemiasterlin derivatives for conjugation and therapy202010,808,039Monomethylvaline compounds capable of conjugation to ligands202010,596,270Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates202010,414,826Monomethylvaline compounds capable of conjugation to ligands201910,000,555Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus20189,522,194'Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminus'20169,034,895'Composition and methods for treating glioblastoma'20158,871,720'Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus'20148,703,714'Monomethylvaline compounds capable of conjugation to ligands'20148,343,928'Monomethylvaline compounds having phenylalanine side-chain replacements at the C-terminus'20138,252,940'5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection'20128,153,843'Antibacterial agents'20128,101,640'Antibacterial agents'20128,084,615'Antibacterial agents'20117,994,135'Monomethylvaline compounds capable of conjugation to ligands'20117,989,660'Antibacterial agents'20117,964,566'Monomethylvaline compounds capable of conjugation to ligands'20117,964,567'Monomethylvaline compounds capable of conjugation to ligands'20117,745,394'Monomethylvaline compounds capable of conjugation to ligands'20105,691,311'Methods for coating invasive devices with inhibitors of thrombin'19975,433,940'Inhibitors of thrombin'19955,196,404'Inhibitors of thrombin'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993Based in New York, NY, US· patent location history
1995–1997Based in Cambridge, MA, US· patent location history
2010–2020Patents assigned to SEATTLE GENETICS INC (11)· patent assignee history
2010–2018Based in Seattle, WA, US· patent location history
2011–2015Patents assigned to KLINE TONI (5)· patent assignee history
2011–2012Patents assigned to UNIV WASHINGTON (5)· patent assignee history
2011–2012Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (4)· patent assignee history
2011–2012Patents assigned to ANDERSEN NIELS H (3)· patent assignee history
2016–2020Based in San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SEATTLE GENETICS INC112010–2020
KLINE TONIself52011–2015
UNIV WASHINGTON52011–2012
NOVARTIS VACCINES & DIAGNOSTIC42011–2012
ANDERSEN NIELS H32011–2012
Locations
LocationPatentsSpan
Seattle, Washington, US142010–2018
San Francisco, California, US52016–2020
Cambridge, Massachusetts, US21995–1997
New York, New York, US11993